Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05981690
Other study ID # UREC 21/27
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 6, 2021
Est. completion date March 28, 2022

Study information

Verified date July 2023
Source University of Reading
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This preliminary study aims to examine the outcomes from a therapist guided, parent-led, CBT treatment for preadolescent children (aged 5 to 12 years old) with OCD. Specifically, this study aims to: 1. Examine outcomes for children who receive the therapist guided, parent-led, CBT treatment for preadolescent children with OCD. 2. Examine parents' experiences and views about the acceptability of the treatment approach.


Description:

This study adapted an existing therapist guided, parent-led CBT intervention for children with anxiety difficulties, to ensure suitability for preadolescent children with OCD. This preliminary study aims to examine the outcomes from a therapist guided, parent-led, CBT treatment for preadolescent children (aged 5 to 12 years old) with OCD. Specifically, this study aims to: 1. Examine outcomes for children who receive the therapist guided, parent-led, CBT treatment for preadolescent children with OCD. 2. Examine parents' experiences and views about the acceptability of the treatment approach.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date March 28, 2022
Est. primary completion date March 3, 2022
Accepts healthy volunteers No
Gender All
Age group 5 Years to 12 Years
Eligibility Inclusion Criteria: Children Inclusion criteria: 1. Aged 5 to 12 years old (when parents/carers complete the baseline questionnaires). 2. Diagnosis of OCD (identified from the ADIS-P). 3. UK-resident. Parents Inclusion criteria: 1. Parent/legal guardian of the child. 2. UK resident. Exclusion Criteria: Children Exclusion criteria: 1. Comorbid condition, which is likely to interfere with treatment delivery, for example: 1. Established Autism Spectrum Condition (ASC). 2. Suspected ASC (indicated by exceeding the threshold of 15 on the Social Communication Questionnaire and where a diagnosis of ASC has not been ruled out by a medical professional). 3. Profound learning difficulty (evidenced by attending a specialist school). 2. Risk and/or safeguarding concerns, which are paramount and would interfere with treatment delivery, for example: 1. Suicidal intent. 2. Recurrent or potentially life limiting self-harm. 3. Significant safeguarding concerns (i.e., if the child has a child protection plan and/or is on the child protection register, and/or the research team consider the child to be suffering, or likely to suffer, significant harm). 3. If children have been prescribed psychotropic medication, the dosage must have been stable for two months. 4. Children who are currently receiving other psychological support/interventions delivered by a mental health professional. Parents Exclusion criteria: 1. Significant intellectual impairment that is likely to interfere with treatment delivery. 2. Unable to access or understand written English language materials needed for the intervention.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Therapist guided, parent-led CBT for preadolescent children with OCD
This treatment was adapted from an existing evidence based therapist guided parent-led CBT intervention for preadolescent children with anxiety difficulties. It consists of 6 to 8 treatment individual treatment sessions where parents learn CBT techniques to apply at home with their child

Locations

Country Name City State
United Kingdom University of Reading Reading UK

Sponsors (1)

Lead Sponsor Collaborator
University of Reading

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Children's Yale Brown Obsessive Compulsive Scale (CY-BOCS) Diagnostic interview. Higher scores indicate higher severity of OCD Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
Secondary Anxiety Disorder Interview Schedule - Parent Report (ADIS-P) Diagnostic interview. Indicates presence/absence of anxiety, OCD, and externalising difficulties. Higher severity scores indicate greater severity of difficulties. Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
Secondary Children's Obsessional Compulsive Inventory - Revised - Parent Report (ChOCI-R-P) Symptom measure. Higher scores indicate greater OCD symptoms and impairment. Weekly during baseline and intervention phase; one month follow up
Secondary Family Accommodation Scale - FAS Symptom measure. Higher scores indicate greater levels of family accommodation of OCD. Weekly during baseline and intervention phase; one month follow up
Secondary Goal Based Outcomes - GBOs Families identify up to 3 personalised goals to work towards during the intervention. Goals are rated weekly by the parent form 0 (no goal progress) to 10 (goal achieved) Weekly during intervention phase; one month follow up
Secondary Session Rating Scale- SRS Therapeutic alliance/treatment acceptability. Higher scores indicate greater acceptability. Weekly during intervention phase; one month follow-up
Secondary Treatment acceptability questions Treatment acceptability. 6 questionnaire items on a Likert scale from strongly disagree to strongly agree. 4 open ended questions regarding treatment acceptability. one month follow-up
Secondary Items assessing parent knowledge of OCD, how to help their child, and confidence to help child 3 questionnaire items devised by study authors to assess parents' report of their knowledge and confidence to help their child to overcome OCD. Items scored from 0 (no new learning) to 5 (learned a lot) Weekly during baseline and intervention phase; one month follow up
Secondary Items assessing how much children have learned new information about their fears/ability to cope in feared situations 2 questionnaire items devised by study authors to assess parents' perceptions of whether their child had learned new information about their fears and their ability to cope in feared situations, without performing their compulsions. Items scored from 0 (no new learning) to 5 (learned a lot) Weekly during intervention phase; one month follow up
See also
  Status Clinical Trial Phase
Completed NCT00523718 - Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder Phase 2
Completed NCT00215137 - Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder Phase 2
Recruiting NCT06050369 - Objective Characterizatoion of Repetitive Behaviors N/A
Recruiting NCT06347978 - Personalized DBS for OCD Guided by Stereoencephalography Mapping N/A
Withdrawn NCT03926546 - Individual Versus Group Exposure With Response Prevention (ERP) for the Treatment of Obsessive Compulsive Disorder (OCD) N/A
Recruiting NCT05712057 - Neurostimulation Versus Therapy for Problems With Emotions N/A
Not yet recruiting NCT03313622 - Locating Biomarkers in OCD Through Behavioral Tasks
Withdrawn NCT03842345 - DELPhI Evaluation of Psychiatric Conditions
Completed NCT02866422 - Development of an Instrument That Monitors Behaviors Associated With OCD N/A
Completed NCT01833442 - Randomized Controlled Meditation Trial for Treating OCD N/A
Recruiting NCT04904952 - Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients N/A
Recruiting NCT02500888 - Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder N/A
Recruiting NCT06244121 - Effect of Pyridoxine as Add-on Therapy in OCD Patients N/A
Recruiting NCT05580614 - Paired tVNS With ERP in OCD N/A
Active, not recruiting NCT03511534 - Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder N/A
Recruiting NCT05624528 - A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder Phase 2
Recruiting NCT05881356 - Discovering Factors in the Clinical Study Journey of Patients With OCD
Recruiting NCT05359562 - How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD N/A
Recruiting NCT03459456 - Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)
Active, not recruiting NCT05930912 - Psychiatric Orders in Psychoanalytic Treatment of ASD